AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TULLOW OIL PLC

Share Issue/Capital Change Jul 2, 2019

4803_rns_2019-07-02_0299db80-8f2e-4807-b7f7-0d83dda4d3c9.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1858E

Tullow Oil PLC

02 July 2019

02 July 2019

The following amendments have been made to the 'Block Listing Application' announcement released on 02 July 2019 at 9am under RNS No 0877E.

Euronext Growth references amended to Euronext Dublin

All other details remain unchanged.

The full amended text is shown below.

Tullow Oil plc

("Tullow Oil " or the "Company")

Block Listing Application

A block listing application has been made for 16,000,000 ordinary shares of 10p each in the Company to be admitted to the Official List of FCA Listing Authority and the Official List of Euronext Dublin, and an application has been made to the London Stock Exchange and Euronext Dublin for trading on their respective main markets.

The new ordinary shares will be issued from time to time to satisfy the issue of shares pursuant to the exercise of options under the Company's Employee Share Award Plan and the Tullow Incentive Plan.

It is expected that admission will become effective on July 4th, 2019.  The shares will be issued fully paid and will rank pari passu in all respects with the existing issued Ordinary Shares of the Company.

Contacts

Tullow Oil plc

Company Secretary, Adam Holland

T: +44 (0) 203 249 9000

E:  [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSUGUMWMUPBURP

Talk to a Data Expert

Have a question? We'll get back to you promptly.